Overview on desonide 0.05%: a clinical safety profile.

Journal of drugs in dermatology : JDD

Volumn 3, Issue 4, 2004, Pages 393-397

  Wong, Vicky Kwan ^a   Fuchs, Brian ^a   Lebwohl, Mark ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; DESONIDE;

CHEMICALLY INDUCED DISORDER; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DERMATITIS; DRUG EFFECT; DRUG HYPERSENSITIVITY; ERYTHEMA; EYE DISEASE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; OINTMENT; POSTMARKETING SURVEILLANCE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEBORRHEIC DERMATITIS; SKIN;

ADMINISTRATION, CUTANEOUS; ANTI-INFLAMMATORY AGENTS; CHILD; CLINICAL TRIALS; DERMATITIS; DERMATITIS, SEBORRHEIC; DESONIDE; DRUG HYPERSENSITIVITY; ERYTHEMA; EYE DISEASES; HUMANS; OINTMENTS; PRODUCT SURVEILLANCE, POSTMARKETING; RANDOMIZED CONTROLLED TRIALS; SKIN;

EID: 16544395718     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)